Skip to content

Effect of percutaneous acupoint electrical stimulation combined with aromatherapy on postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery

Effect of percutaneous acupoint electrical stimulation combined with aromatherapy on postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090225
Enrollment
Unknown
Registered
2024-09-26
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting

Interventions

Percutaneous acupoint electrical stimulation group(T group):Percutaneous acupoint electrical stimulation was performed 30 minutes before anesthesia and 30 minutes after admission to PACU. The electrod
Aromatherapy group(A group):30 minutes before the end of the operation, 5 drops of peppermint solution were injected into the humidified respiratory circuit filter. After the operation, 5 drops of pep
Percutaneous acupoint electrical stimulation combined with aromatherapy group(D group):Group T and Group A jointly implemented
Blank control group(C group):No intervention is imposed

Sponsors

The First Affiliated Hospital of Wannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Female: age 18-60 years old; 2.ASA grades I~II; 3.BMI 18.5~24kg/m^2; 4. Operation duration > 60 minutes

Exclusion criteria

Exclusion criteria: 1. Previous history of postoperative nausea and vomiting or motion sickness; 2. History of smoking and asthma; 3. Previous history of allergy to peppermint and its analogues; 4. Used antiemetic drugs within 24 hours before surgery; 5. Severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction; 6. Long-term use of glucocorticoids, chemoradiotherapy drugs, psychotherapeutic drugs.

Design outcomes

Primary

MeasureTime frame
The incidence of 0-6h and 6-24 HPONV;Postoperative pain scores at 6h and 24hVAS;

Secondary

MeasureTime frame
Number of times remedial antiemetics were used;First postoperative exhaust time;

Countries

China

Contacts

Public ContactGuo Wenjun

The First Affiliated Hospital of Wannan Medical College

gwj8581@sina.com+86 136 0553 2244

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026